Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.54 |
| ▸ | AR | P10275 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MAOB | P27338 | 4/20 | 0.49 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5577096 | 0.88 | RAB9A (0.62) | RAB9ANPC1GSTO1LMNASMN1; SMN2 | |
| SCHEMBL5577099 | 0.83 | RAB9A (0.55) | RAB9ANPC1GSTO1LMNASMN1; SMN2 | |
| SCHEMBL7258047 | 0.81 | RAB9A (0.70) | RAB9ANPC1GSTO1LMNASMN1; SMN2 | |
| SCHEMBL3144530 | 0.80 | LMNA (0.50) | RAB9ANPC1LMNASMN1; SMN2KDM4E | |
| SCHEMBL3144521 | 0.80 | LMNA (0.50) | RAB9ANPC1LMNASMN1; SMN2KDM4E | |
| SCHEMBL3139858 | 0.80 | LMNA (0.50) | RAB9ANPC1LMNASMN1; SMN2KDM4E | |
| SCHEMBL3139877 | 0.80 | LMNA (0.50) | RAB9ANPC1LMNASMN1; SMN2KDM4E | |
| SCHEMBL3139846 | 0.80 | LMNA (0.50) | RAB9ANPC1LMNASMN1; SMN2KDM4E | |
| SCHEMBL7241453 | 0.79 | RAB9A (0.65) | RAB9ANPC1GSTO1LMNASMN1; SMN2 | |
| SCHEMBL2559540 | 0.77 | RAB9A (0.65) | RAB9ANPC1GSTO1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030055263-A1 | Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055263-A1 | Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production | TERT, POT1, REV1 | RAB9A 3964/4885NPC1 2716/4885GSTO1 1600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.